Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.

Similar Items

• T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
  by: Novitzky, N, et al.
  Published: (1997)
• Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
  by: Novitzky, N, et al.
  Published: (1999)
• In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
  by: Willemze, R, et al.
  Published: (1992)
• Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
  by: Heit, W, et al.
  Published: (1986)
• T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
  by: Jacobs, P, et al.
  Published: (1994)